Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Clin Cancer Res. 2020 Jul 24;26(21):5701–5708. doi: 10.1158/1078-0432.CCR-20-1825

Figure 3.

Figure 3.

Survival by SMARCA4 alteration class. (A) Overall survival among all patients, with multivariate model (right). (B) Overall survival among patients with KRAS mutations, with multivariate model (right).